"Designing Growth Strategies is in our DNA"

Bone Growth Stimulators Market Size, Share and Global Trend By Product Type (Bone Growth Stimulation Devices, Bone Morphogenetic Proteins (BMP), Platelet-Derived Growth Factor (PDGF)), By Application (Spinal Fusion, Maxillofacial & Dental, Nonunion and Union Bone Fractures), By End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Home Care), and Geography Forecast till 2026

Region : Global | Latest Update: Jul, 2019 | Published Date: Apr, 2019 | Report ID: FBI100161| Status : Published



The Global Bone Growth Stimulators Market, which was valued at US$ 1,837.2 Mn in 2018, is estimated to reach US$ 2,624.8 Mn by the end of 2026, registering a CAGR of 4.6%.The cases of bone fractures and sports injuries are increasing gradually, augmenting the demand for bone growth stimulators across the globe. Bone growth stimulation devices and products have positively impacted orthopedic surgeries. The market potential of bone growth stimulators has initiated various clinical studies on bone morphogenetic proteins.

Bone growth stimulators have wide application in spinal fusion, dental, maxillofacial, fracture repair, and many others. The rising prevalence of osteoarthritis and degenerative bone diseases are also contributing to the bone growth stimulators market. Also, rapid adoption and demand for bone morphogenetic proteins and platelet-derived growth factors owing to improved healing results is also expected to boost the bone growth stimulators market. 

Get comprehensive study about this report by, request a sample copy

Bone Growth Stimulation Devices to Dominate the Global Bone Growth Stimulators Market 

Bone growth stimulation devices consist of electrical devices, implantable devices, and ultrasound devices. The segment is estimated to hold a share of 52.0% in the global bone growth stimulators market. This can be attributed to the favorable health reimbursement for the devices, rapid adoption for ultrasonic devices, and increasing cases of delayed union and nonunion fractures. Platelet-Derived Growth Factor (PDGF) segment is estimated to grow remarkably, owing to the increased research and pipeline candidates for application in bone stimulation.

To get details on market share, speak to our analyst

In terms of application, the bone growth stimulators market is categorized into spinal fusion, maxillofacial & dental, nonunion and union bone fractures, and others. Spinal fusion segment accounted for maximum market share in 2018, owing to the increased clinical evidence for the use of bone stimulation devices for spinal fusion and rise in number of spinal fusion surgeries across the globe. Nonunion and union bone fractures segment witnesses the highest growth due to the increased cases of sports injuries and rising trend for home care stimulation devices. Hospitals, ambulatory surgical centres, speciality clinics, and home care are the major end users of the bone growth stimulation products. 

New Product Approvals to drive the Bone Growth Stimulators Market in North America and Europe

North America generated maximum revenue of US$ 760.2 Mn in 2018 and is estimated to dominate the market throughout the forecast duration. Improving health reimbursement for stimulation devices, clinical research to extend the application of the devices, and strategic presences of major manufacturers in the U.S. are the factors responsible for the growth in North America during 2018-2026. In terms of revenues, Europe is projected to be the second dominant region. Furthermore, the FDA and CE approval for CervicalStim and SpinalStim bone stimulation devices is expected to fuel the growth of bone growth stimulators market in North America and Europe.  Asia Pacific is expected to register the highest CAGR during the forecast period which is attributable to the increasing demand for orthopedic products and rising number of standalone orthopedic clinics. 

North America Bone Growth Stimulators Market, 2018

To get geographical overview of this market, request a sample copy

Zimmer Biomet and Orthofix Holdings, Inc. to lead the Bone Growth Stimulators Market 

Zimmer Biomet and Orthofix Holdings, Inc. account for majority of the share in the global bone growth stimulators market mainly due to the diversified product portfolio of Zimmer Biomet and new product approvals received by Orthofix Holdings, Inc. Orthofix Holdings, Inc. received both FDA and CE approval for CervicalStim and SpinalStim bone growth stimulators, which is estimated to strengthen the company position in the bone growth stimulators market. Other players operating in the global bone growth stimulators market are Stryker, Medtronic, Bioventus, Wright Medical Group N.V., Prospec-Tany Technogene Ltd., Elizur Corporation, Ossatec Benelux BV, and IGEA S.p.a. 

Market Overview  

Increase in number of sports injuries, favorable health reimbursement, and emerging clinical evidence of bone stimulation has led to an increased preference for bone stimulation devices by health care professionals. Furthermore, the emergence of bone morphogenetic proteins (BMP) have revolutionized the bone stimulation techniques and have initiated research on many pipeline candidates which will favor the market potentials of bone growth stimulators. 

The report provides qualitative and quantitative insights on the bone growth stimulators industry and detailed analysis of market size and growth rate for all possible segments in the market. The market is segmented based on product type, application, end user, and geography. In terms of product type, the global bone growth stimulators market is segmented into bone growth stimulation devices, bone morphogenetic proteins (BMP) and platelet-derived growth factor (PDGF). The bone growth stimulation devices market is further classified into electrical bone growth stimulators (Capacitive Coupling (CC) devices, Combined Magnetic Field devices (CMF), and Pulsed Electromagnetic Field (PEMF) devices), implantable bone growth stimulators, and ultrasound bone growth stimulators.  On the basis of application, the market is categorized into spinal fusion, maxillofacial & dental, nonunion and union bone fractures, and others. The end user for bone growth stimulators products includes hospitals, ambulatory surgical centres, specialty clinics, home care, and others. Geographically, the market is segmented into five major regions, which are North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The regions are further categorized into countries. 

Along with this, the report provides elaborative analysis of the market dynamics and competitive landscape. Key insights provided in the report include the number of spinal fusion surgery for key countries, overview of health reimbursement, regulatory scenario in key countries, new product launch, pipeline analysis, key mergers and acquisition, recent industry trends, and others.

To get information on various segments, share your queries with us





By Product Type

·      Bone Growth Stimulation Devices

·      Electrical Bone Growth Stimulators

·      Capacitive Coupling (CC) Devices

·      Combined Magnetic Field Devices (CMF)

·      Pulsed Electromagnetic Field Devices (PEMF)

·      Implantable Bone Growth Stimulators

·      Ultrasonic Bone Growth Stimulators

·      Bone Morphogenetic Proteins (BMP)

·      Platelet-Derived Growth Factor (PDGF)

By Application

·      Spinal Fusion

·      Maxillofacial & Dental

·      Nonunion and Union Bone Fractures

·      Others

By End User

·      Hospitals

·      Ambulatory Surgical Centers

·      Specialty Clinics

·      Home Care

·      Others

By Geography

·      North America (USA and Canada)

·      Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)

·      Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)

·      Latin America (Brazil, Mexico and Rest of Latin America)

·      Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)



  • Zimmer Biomet

  • Stryker

  • Medtronic

  • Wright Medical Group N.V.  

  • Orthofix Holdings, Inc.

  • Prospec-Tany Technogene Ltd.

  • Elizur Corporation

  • Bioventus  

  • Ossatec Benelux BV

  • IGEA S.p.a

  • Other players

We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . More info.